1. Home
  2. YMAB vs CMDB Comparison

YMAB vs CMDB Comparison

Compare YMAB & CMDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • CMDB
  • Stock Information
  • Founded
  • YMAB 2015
  • CMDB 2023
  • Country
  • YMAB United States
  • CMDB Monaco
  • Employees
  • YMAB N/A
  • CMDB N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • CMDB
  • Sector
  • YMAB Health Care
  • CMDB
  • Exchange
  • YMAB Nasdaq
  • CMDB Nasdaq
  • Market Cap
  • YMAB 192.4M
  • CMDB 209.8M
  • IPO Year
  • YMAB 2018
  • CMDB N/A
  • Fundamental
  • Price
  • YMAB $4.32
  • CMDB $9.10
  • Analyst Decision
  • YMAB Buy
  • CMDB
  • Analyst Count
  • YMAB 11
  • CMDB 0
  • Target Price
  • YMAB $17.55
  • CMDB N/A
  • AVG Volume (30 Days)
  • YMAB 182.8K
  • CMDB 109.1K
  • Earning Date
  • YMAB 08-11-2025
  • CMDB 08-12-2025
  • Dividend Yield
  • YMAB N/A
  • CMDB N/A
  • EPS Growth
  • YMAB N/A
  • CMDB N/A
  • EPS
  • YMAB N/A
  • CMDB N/A
  • Revenue
  • YMAB $88,658,000.00
  • CMDB $1,195,401,000.00
  • Revenue This Year
  • YMAB N/A
  • CMDB N/A
  • Revenue Next Year
  • YMAB $15.15
  • CMDB N/A
  • P/E Ratio
  • YMAB N/A
  • CMDB N/A
  • Revenue Growth
  • YMAB 4.92
  • CMDB 80.27
  • 52 Week Low
  • YMAB $3.55
  • CMDB $8.46
  • 52 Week High
  • YMAB $16.11
  • CMDB $11.99
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 43.02
  • CMDB N/A
  • Support Level
  • YMAB $4.23
  • CMDB N/A
  • Resistance Level
  • YMAB $4.62
  • CMDB N/A
  • Average True Range (ATR)
  • YMAB 0.24
  • CMDB 0.00
  • MACD
  • YMAB -0.03
  • CMDB 0.00
  • Stochastic Oscillator
  • YMAB 14.04
  • CMDB 0.00

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About CMDB Costamare Bulkers Holdings Limited Common Stock

Costamare Bulkers Holdings Ltd is an international owner and operator of dry bulk vessels providing multinational transportation of dry bulk commodities for a broad range of customers. Its owned fleet consists of 38 vessels, with a total carrying capacity of approximately 3,017,000 dwt. The company's vessels transport a broad range of major and minor bulks across global shipping routes. Iron ore, coal and grain constitute the majority of its cargoes.

Share on Social Networks: